| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-19 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-17 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |